Long Term Remission and Cardiac Toxicity of a Combination of Ipilimumab and Nivolumab in a Patient With Metastatic Head and Neck Carcinoma After Progression Following Nivolumab Monotherapy

Overview of attention for article published in Frontiers in oncology, May 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 27,884 followers.

RT @CastlDalmunzie: #clinicalpearl #immunotherapy #preventativeoncology #CancerResearch #cardiooncology Long Term Remission & #CardiacToxic…

19 May 2019

Reply Repost Favourite

RT @FrontOncology: New research: Long Term Remission and Cardiac Toxicity of a Combination of Ipilimumab and Nivolumab in a Patient With Me…

19 May 2019

Reply Repost Favourite

New research: Long Term Remission and Cardiac Toxicity of a Combination of Ipilimumab and Nivolumab in a Patient With Metastatic Head and Neck Carcinoma After Progression Following Nivolumab Monotherapy: Management of patients with metastatic… https://t.co

19 May 2019

Reply Repost Favourite

#clinicalpearl #immunotherapy #preventativeoncology #CancerResearch #cardiooncology Long Term Remission & #CardiacToxicity of #Ipilimumab - #Nivolumab in Metastatic #HeadNeckCancer After Progression Following #Nivolumab #Monotherapy https://t.co/TBenyI

16 May 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.